TJP1 and hepatocellular carcinoma: It is also highly expressed in patients with liver cancer, and it enhances the invasiveness of hepatoma cells by directly binding to 3′ untranslated region (3′-UTR) and inhibiting the expression of zone occlusion-1 (ZO-1).